Institutional Cluster

GMAB

GENMAB A/S
BEARISH
Impact 4/10
Horizonweeks Processed3mo ago
Institutional cluster: 2 buyers, 4 sellers (mixed)
Actionable Insight ▼ Bearish

The cluster is dominated by passive fund rebalancing on both sides, but Citadel's near-total exit of a large position is a notable active-manager signal. Monitor for any fundamental deterioration or catalyst that could explain the selling. The buying from Fidelity and Schwab is likely mechanical and does not offset the bearish signal from the sellers.

DirectionBearish
Confidencemedium
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
GMAB ▲ +33.12% at T+60d
SHORT call ✗ call lost -33.12% · α vs SPY -28.73% · entry $25.24 → $33.60
Entry anchored
Jun 10, 03:59 PM ET
via exchange tick
T+1d
-0.63%
call +0.63% · α +1.17%
$25.08
settled 4mo ago
T+5d
+0.59%
call -0.59% · α -0.16%
$25.39
settled 4mo ago
T+20d
+17.99%
call -17.99% · α -16.10%
$29.78
settled 3mo ago
T+60d
+33.12%
call -33.12% · α -28.73%
$33.60
settled 24d ago

Executive Summary

An institutional cluster in GMAB shows mixed conviction: two passive funds (Fidelity, Schwab) added $21.8M in new holdings, while four institutions (including Citadel and three passive managers) reduced positions by $85.7M. The net selling pressure of ~$63.9M from the sellers, led by Citadel's near-exit of a $73.7M position, dominates the cluster signal and suggests caution despite the buying activity.

Key Financial Metrics

Direction
distributing
Buy Value
$37.4M
Sell Value
$151.1M
Net Flow
-$63.9M

Institutional Positions

Net institutional flow: -$63.9M

▲ Buyers (2)

InstitutionActionChangePosition ValueValue Δ
FidelityADD+64.5%$34.3M$20.3M
SchwabADD+32.3%$3.1M$1.5M

▼ Sellers (4)

InstitutionActionChangePrev ValueValue Δ
CitadelNEAR_EXIT-98.6%$73.7M-$72.2M
UBSNEAR_EXIT-83.1%$10.0M-$7.5M
Morgan StanleyTRIM-37.9%$55.7M-$4.4M
BofATRIM-42.2%$11.7M-$1.7M

Key Facts

  • 2 buyers added $21.8M in new holdings (Fidelity +$20.3M, Schwab +$1.5M)
  • 4 sellers reduced positions by $85.7M (Citadel -$72.2M, UBS -$7.5M, Morgan Stanley -$4.4M, BofA -$1.7M)
  • Citadel executed a near-exit, reducing a $73.7M position to $1.6M (-98.6% of shares)
  • All buyers are mega-passive funds (likely index rebalancing), while sellers include one active quant (Citadel) and three passive managers
  • Net aggregate change: -$63.9M (sellers outweigh buyers by ~3:1 in dollar terms)

Financial Impact

Net institutional selling of ~$63.9M in Q3 2025, with total seller reductions of $85.7M versus buyer additions of $21.8M

institutional holdingsfloat allocation

Risk Factors

  • 13F data is 45+ days stale; positions may have been further adjusted since quarter-end
  • Passive fund activity may reflect index rebalancing rather than fundamental conviction
  • Historical reports on GMAB show negative T+20 performance (-12.88% on prior bullish call), suggesting the stock has been difficult to time

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
76% bullish (25 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-GMAB-2025-Q3
13 reports for GMAB
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60▲ +26.50%Jun 29, 2026
Filters
Rows
Reports for GMAB — sortable, filterable
TypeNow
Sep 8, 2026
24d ago
6-K
NEUTRAL ★ 2/10
$33.53 $32.65▼ −2.62%▼ −1.96%—
Aug 12, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$31.42 $34.11▲ +8.56%▲ +9.01%—
Aug 11, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$30.85 $32.96▲ +6.84%▲ +7.24%—
Aug 6, 2026
8w ago
6-K
BULLISH ★ 6/10
$29.83 $31.34▲ +5.06%▲ +3.85%—
Jul 15, 2026
11w ago
6-K
NEUTRAL ★ 3/10
$29.08 $28.85▼ −0.79%▲ +0.19%—
Jun 29, 2026
13w ago
6-K
BULLISH ★ 7/10
$27.47 $28.01▲ +1.97%▲ +1.36%—
Jun 17, 2026
15w ago
6-K
NEUTRAL ★ 2/10
$25.39 $25.87▲ +1.87%▲ +2.91%—
Jun 16, 2026
15w ago
6-K
NEUTRAL ★ 1/10
$24.74 $25.94▲ +4.85%▲ +7.08%—
Jun 15, 2026
15w ago
6-K
NEUTRAL ★ 2/10
$24.58 $25.61▲ +4.19%▲ +5.57%—
Jun 15, 2026
15w ago
6-K
NEUTRAL ★ 2/10
$24.58 $25.61▲ +4.19%▲ +5.57%—
Showing 10 of 13

US Market Status

Market Open — Closes in 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 11, 2026